Friday 6 November 2026 Export JNJ’s income statement to Excel — free account

Johnson & Johnson

JNJ Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024.

Revenue: +5.86%
EPS: −95.8%
Free cash flow: −21.4%
Total debt: −9.16%

Quarter to September 2026, against a year earlier

275.17 2.85 +1.05%

Follow JNJ

Alert me

Market cap: $655.6B
P/E: 41.3×
Fwd P/E: 40.0×
Dividend yield: 1.94%
F-score: 3/9
Altman Z: 4.78
Beneish M: −2.26
Dividend safety: 78/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	18.73	28.26	29.43	40.11
P/S ratio Full definition →		5.29	6.11	6.24	6.42
P/FCF ratio Full definition →		24.40	32.26	26.91	30.39
P/Operating CF Full definition →		68.16	234.20	70.96	82.63
P/B ratio Full definition →		6.11	7.25	7.20	7.82
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		5.49	6.27	6.41	6.61
EV/EBITDA Full definition →		12.29	17.43	18.01	23.71
EV/Operating CF Full definition →		21.10	26.42	22.75	25.10
EV/FCF Full definition →		25.35	33.10	27.64	31.28
Quick Ratio Full definition →		0.69	0.69	0.73	0.65
Current Ratio Full definition →		1.03	1.03	1.09	1.02
Net Debt/EBITDA Full definition →		2.60	1.82	1.80	7.27
Debt/Assets Full definition →		19.80%	18.68%	18.57%	18.13%
Debt/Equity Full definition →		0.48	0.46	0.44	0.44
Asset Turnover Full definition →		0.50	0.49	0.50	0.51
Operating CF/Net income Full definition →		1.43	0.48	1.56	36.76
Capex/Depreciation Full definition →		(0.76)	(0.51)	(0.64)	(0.65)
Interest Coverage Full definition →		25.31	23.86	25.79	2.01
Research and Development Expense of Revenue Full definition →		17.31%	14.66%	14.43%	18.32%
Selling, General and Administrative Expense of Revenue Full definition →		27.49%	25.08%	25.41%	24.75%
Intangible Assets out of Total Assets Full definition →		0.50	0.49	0.48	0.48
Share Based Compensation of Revenue Full definition →		1.26%	1.25%	1.81%	1.41%
Graham Net Nets Full definition →		(0.12)	(0.10)	(0.09)	(0.09)
Graham Number Full definition →		91.77	80.99	82.79	70.88
Earnings Yield Full definition →		5.34%	3.54%	3.40%	2.49%
Free Cash Flow Yield Full definition →		4.10%	3.10%	3.72%	3.29%
Revenue per Share Full definition →		10.20	9.99	10.51	10.54
Operating CF per Share Full definition →		3.04	1.04	3.58	3.20
Capex per Share Full definition →		(0.63)	(0.42)	(0.52)	(0.57)
Free Cash Flow per Share Full definition →		2.40	0.62	3.06	2.64
Cash per Share Full definition →		8.35	9.15	8.62	7.15
Shareholders Equity per Share Full definition →		33.87	33.71	35.30	33.84
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		33.87	33.71	35.30	33.84
Free Cash Flow Full definition →		5,784.00	1,494.00	7,358.00	6,354.00
Working Capital Full definition →		1,498.00	1,457.00	4,879.00	894.00
Capital Expenditures Full definition →		(1,525.00)	(1,020.00)	(1,258.00)	(1,366.00)
Net Current Asset Value Full definition →		(62,042.00)	(60,535.00)	(56,316.00)	(59,545.00)
EV/EBIT Full definition →		14.95	22.44	23.16	33.51
Capex to Sales Full definition →		0.06	0.04	0.05	0.05
Price to Operating Income Full definition →		15.29	23.61	24.27	35.97
Other line items
Average Receivables Full definition →		16,010.00	16,870.50	18,446.00	18,299.00
Average Payables Full definition →		11,151.00	10,002.50	9,343.50	9,471.00
Average Inventory Full definition →		13,317.50	13,621.00	14,278.00	14,761.50
Average Assets Full definition →		189,657.00	197,282.50	197,225.00	195,120.50
Average Common Equity Full definition →		76,517.00	79,647.50	81,722.00	80,403.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly